Qiagen N.V. (QGEN)
$45.31-0.15%Close
BUYRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.3B
- Beta
- 0.63
- Div yield
- 5.78%
- P/E (TTM)
- 23.41
- Short % float
- 3.75%
- Days to cover
- 3.6
- SI change
- +0.2%
- 1W
- -1.05%
- 1M
- +6.61%
- vs SPY 1W
- -1.47%
- vs SPY 1M
- +4.55%
Industry peers
FMP comparable companies · ranked by market cap
- TMOBUYThermo Fisher Scientific Inc.$244.9BBULLQ 18$662.24+0.64%
- DHRBUYDanaher Corporation$155.5BRECOVERYQ 36$221.20+0.63%
- ABUYAgilent Technologies, Inc.$48.4BBULLQ 16$171.33+0.46%
- RVTYBUYRevvity, Inc.$17.4BBULLQ 12$155.61+0.93%
- TECHBUYBio-Techne Corporation$11.4BBULLQ 19$72.56+0.14%
- BIOSELLBio-Rad Laboratories, Inc.$9.8BBEARQ 19$364.42-0.48%
- RGENSELLRepligen Corporation$9.7BBEARQ 26$172.51-0.79%
- TXGBUY10x Genomics, Inc.$9.5BCRISISQ 11$75.19-6.77%
- BRKRSELLBruker Corporation$8.6BBEARQ 8$56.25-4.40%
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.0BCRISISQ -2$7.06-5.11%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on QGEN?
- LOPJLB’s latest quantitative signal on Qiagen N.V. (QGEN) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is QGEN in?
- Qiagen N.V. (QGEN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Qiagen N.V. (QGEN) do?
- Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead techn…